Great Novel Therapeutics Biotech & Medicals
7427.TWO
Price:
$34.35
Market Cap:
$1.48B
Great Novel Therapeutics Biotech & Medicals engages in the development of drugs for the treatment of advanced and refractory cancers. It develops drugs for cancer immunotherapy, including tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was formerly known as GNT Biotech & Medicals Corporation. Great Novel Therapeutics Biotech & Medicals was founded in 2013 and is based in Taipei City, Taiwan.
Industry
Biotechnology
IPO Date
2021-07-08
Stock Exchange
TWO
Ticker
7427.TWO
PE Ratio
[-17.26]
ROE
[-14.66%]
Current Ratio
[30.32]
Dividend Yield
[0%]
Enterprise Value
[1.30B]
Dividend History
The ROE as of December 2025 (TTM) for Great Novel Therapeutics Biotech & Medicals (7427.TWO) is -14.66%
According to Great Novel Therapeutics Biotech & Medicals’s latest financial reports and current stock price. The company's current ROE is -14.66%. This represents a change of 107.04% compared to the average of -7.08% of the last 4 quarters.
Great Novel Therapeutics Biotech & Medicals (7427.TWO) Historical ROE (quarterly & annually)
How has 7427.TWO ROE performed in the past?
The mean historical ROE of Great Novel Therapeutics Biotech & Medicals over the last ten years is -21.62%. The current -14.66% ROE has changed -32.19% with respect to the historical average. Over the past ten years (40 quarters), 7427.TWO's ROE was at its highest in in the June 2019 quarter at 0%. The ROE was at its lowest in in the June 2020 quarter at -16.67%.
Average
-21.62%
Median
-16.89%
Minimum
-44.59%
Maximum
-9.96%
Great Novel Therapeutics Biotech & Medicals (7427.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Great Novel Therapeutics Biotech & Medicals ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 66.38%
Maximum Annual ROE = -9.96%
Minimum Annual Increase = -41.83%
Minimum Annual ROE = -44.59%
| Year | ROE | Change |
|---|---|---|
| 2024 | -16.57% | 66.38% |
| 2023 | -9.96% | -35.59% |
| 2022 | -15.46% | -10.17% |
| 2021 | -17.21% | -33.64% |
| 2020 | -25.94% | -41.83% |
Great Novel Therapeutics Biotech & Medicals (7427.TWO) Average ROE
How has 7427.TWO ROE performed in the past?
The current ROE of Great Novel Therapeutics Biotech & Medicals (7427.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-13.99%
5-year avg
-17.03%
10-year avg
-21.62%
Great Novel Therapeutics Biotech & Medicals (7427.TWO) ROE vs. Peers
How is 7427.TWO’s ROE compared to its peers?
Great Novel Therapeutics Biotech & Medicals’s ROE is greater than GeneReach Biotechnology Corp. (-19.92%), greater than MegaPro Biomedical Co., Ltd (-91.17%), greater than NaviFUS Corp. (-20.73%), greater than Enimmune corporation (-70.32%), greater than Lukas Biomedical Inc. (-31.59%), greater than Bio Preventive Medicine Corp. (-24.73%), greater than LabTurbo Biotech Corporation (-12.54%), less than BiOptic Inc. (4.93%), greater than NeoCore Technology Co., Ltd. (-5.81%), greater than NatureWise Biotech & Medicals Corporation (-5.58%),
| Company | ROE | Market cap |
|---|---|---|
| -19.92% | $1.10B | |
| -91.17% | $1.02B | |
| -20.73% | $1.45B | |
| -70.32% | $1.44B | |
| -31.59% | $1.33B | |
| -24.73% | $1.14B | |
| -12.54% | $1.12B | |
| 4.93% | $1.36B | |
| -5.81% | $1.52B | |
| -5.58% | $1.04B |
Build a custom stock screener for Great Novel Therapeutics Biotech & Medicals (7427.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Great Novel Therapeutics Biotech & Medicals using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Great Novel Therapeutics Biotech & Medicals (7427.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Great Novel Therapeutics Biotech & Medicals or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Great Novel Therapeutics Biotech & Medicals's ROE?
How is the ROE calculated for Great Novel Therapeutics Biotech & Medicals (7427.TWO)?
What is the highest ROE for Great Novel Therapeutics Biotech & Medicals (7427.TWO)?
What is the 3-year average ROE for Great Novel Therapeutics Biotech & Medicals (7427.TWO)?
What is the 5-year average ROE for Great Novel Therapeutics Biotech & Medicals (7427.TWO)?
How does the current ROE for Great Novel Therapeutics Biotech & Medicals (7427.TWO) compare to its historical average?